Article
Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany.
Microbial drug resistance (Larchmont, N.Y.) - 1 Jan 2000
Werner G, Klare I, Heier H, Hinz K H, Böhme G, Wendt M, Witte W
Abstract excerpt
The semisynthetic streptogramin combination quinupristin/dalfopristin (Synercid) is a promising alternative for treatment of infections due to multiply resistant gram-positive bacteria including vancomycin-resistant Enterococcus faecium. Resistance is mediated by acetyltransferases SatA (VatD) or SatG (VatE). Recent papers have indicated a possible link between the use of the streptogramin virginiamycin S/M as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
